España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Xenon Pharmaceuticals
XENE
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$39.80
0.46
1.17%
At close: -
$39.80
0
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Xenon Pharmaceuticals (XENE) Forecast
News
Earnings
Xenon Pharmaceuticals (XENE) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Xenon Pharmaceuticals (NASDAQ:XENE) Stock
Xenon Pharmaceuticals Stock (NASDAQ: XENE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 13, 2024
HC Wainwright & Co. Reiterates Buy on Xenon P...
Benzinga Newsdesk
Needham Reiterates Buy on Xenon Pharmaceutica...
Benzinga Newsdesk
Tuesday, November 12, 2024
Xenon Pharmaceuticals Q3 2024 GAAP EPS $(0.81...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
Earnings Preview: Xenon Pharmaceuticals
Benzinga Insights
Thursday, October 10, 2024
Raymond James Reinstates Outperform on Xenon ...
Benzinga Newsdesk
Tuesday, October 01, 2024
HC Wainwright & Co. Initiates Coverage On Xen...
Benzinga Newsdesk
Tuesday, September 03, 2024
RBC Capital Reiterates Outperform on Xenon Ph...
Benzinga Newsdesk
Monday, August 12, 2024
Xenon Expands Leadership Team With Matthew D....
Benzinga Newsdesk
Needham Maintains Buy on Xenon Pharmaceutical...
Benzinga Newsdesk
Friday, August 09, 2024
Cantor Fitzgerald Reiterates Overweight on Xe...
Benzinga Newsdesk
Wedbush Maintains Outperform on Xenon Pharmac...
Benzinga Newsdesk
Thursday, August 08, 2024
Xenon Pharmaceuticals Q2 2024 GAAP EPS $(0.75...
Benzinga Newsdesk
Tuesday, June 18, 2024
RBC Capital Reiterates Outperform on Xenon Ph...
Benzinga Newsdesk
Tuesday, May 28, 2024
Xenon Pharmaceuticals Presents Phase 2 X-NOVA...
Benzinga Newsdesk
Friday, May 10, 2024
Needham Maintains Buy on Xenon Pharmaceutical...
Benzinga Newsdesk
Citigroup Maintains Buy on Xenon Pharmaceutic...
Benzinga Newsdesk
Wedbush Maintains Outperform on Xenon Pharmac...
Benzinga Newsdesk
Thursday, May 09, 2024
Xenon Pharmaceuticals Q1 2024 Adj EPS $(0.62)...
Benzinga Newsdesk
Tuesday, April 16, 2024
Xenon Pharmaceuticals Announced Two Oral Pres...
Benzinga Newsdesk
Friday, April 12, 2024
Needham Reiterates Buy on Xenon Pharmaceutica...
Benzinga Newsdesk
Wednesday, April 10, 2024
Cantor Fitzgerald Reiterates Overweight on Xe...
Benzinga Newsdesk
Friday, March 01, 2024
RBC Capital Maintains Outperform on Xenon Pha...
Benzinga Newsdesk
Wedbush Maintains Outperform on Xenon Pharmac...
Benzinga Newsdesk
Needham Maintains Buy on Xenon Pharmaceutical...
Benzinga Newsdesk
Thursday, February 29, 2024
Xenon Pharmaceuticals Anticipates Having Suff...
Benzinga Newsdesk
Xenon Pharmaceuticals Q4 EPS $(0.64) Beats $(...
Benzinga Newsdesk
Earnings Scheduled For February 29, 2024
Benzinga Insights
Wednesday, February 28, 2024
Earnings Outlook For Xenon Pharmaceuticals
Benzinga Insights
Friday, February 16, 2024
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
Vandana Singh
Monday, January 08, 2024
Xenon Pharmaceuticals Outlines Key Milestone ...
Benzinga Newsdesk
Thursday, January 04, 2024
Citigroup Initiates Coverage On Xenon Pharmac...
Benzinga Newsdesk
Tuesday, January 02, 2024
B of A Securities Maintains Buy on Xenon Phar...
Benzinga Newsdesk
Monday, December 18, 2023
Stifel Maintains Buy on Xenon Pharmaceuticals...
Benzinga Newsdesk
Friday, December 08, 2023
4 Analysts Have This to Say About Xenon Pharmaceuticals
Benzinga Insights
Baird Initiates Coverage On Xenon Pharmaceuti...
Benzinga Newsdesk
Thursday, November 30, 2023
Why Xenon Pharmaceuticals Stock (XENE) Is Seeing Blue Skies Today
Henry Khederian
Xenon Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Xenon Pharmaceuticals Prices Its Upsized $300...
Benzinga Newsdesk
Wednesday, November 29, 2023
Xenon Pharmaceuticals Commences Underwritten ...
Benzinga Newsdesk
Tuesday, November 28, 2023
Boeing To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Tuesday
Lisa Levin
RBC Capital Maintains Outperform on Xenon Pha...
Benzinga Newsdesk
Monday, November 27, 2023
Xenon Pharma's Depression Candidate Shows Positive Signals Of Efficacy, Despite Primary Endpoint Miss: Analyst
Vandana Singh
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
What's Going On With Neurology-Focused Xenon Pharmaceuticals' Stock Today?
Vandana Singh
Ituran Location and Control Posts Q3 Results, Joins Crown Castle, Shopify And Other Big Stocks Moving Higher On Monday
Lisa Levin
Xenon Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Xenon Pharmaceuticals Released Topline Result...
Benzinga Newsdesk
Friday, November 10, 2023
Why Is Neurocrine Biosciences Stock Trading Lower Today?
Vandana Singh
Thursday, November 09, 2023
Xenon Pharmaceuticals Provides Update On Part...
Benzinga Newsdesk
Show More